Processing

Please wait...

PATENTSCOPE will be unavailable a few hours for maintenance reason on Saturday 31.10.2020 at 2:00 PM JST
Settings

Settings

Goto Application

1. WO2020182197 - LIQUID COMPOSITION COMPRISING ANTIBODY OF HUMAN INTERLEUKIN-4 RECEPTOR ALPHA

Publication Number WO/2020/182197
Publication Date 17.09.2020
International Application No. PCT/CN2020/079120
International Filing Date 13.03.2020
IPC
A61K 39/395 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
39Medicinal preparations containing antigens or antibodies
395Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
C07K 16/28 2006.01
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
KPEPTIDES
16Immunoglobulins, e.g. monoclonal or polyclonal antibodies
18against material from animals or humans
28against receptors, cell surface antigens or cell surface determinants
A61P 29/00 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
29Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (NSAIDs)
A61P 37/08 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
37Drugs for immunological or allergic disorders
08Antiallergic agents
Applicants
  • 苏州康乃德生物医药有限公司 SUZHOU CONNECT BIOPHARMACEUTICALS, LTD. [CN]/[CN]
Inventors
  • 郑伟 ZHENG, Wei
  • 潘武宾 PAN, Wubin
  • 杨欣 YANG, Xin
  • 张立民 ZHANG, Limin
  • 蒋洁 JIANG, Jie
Agents
  • 北京瑞恒信达知识产权代理事务所(普通合伙) LEADING INTELLECTUAL PROPERTY FIRM
Priority Data
201910187179.913.03.2019CN
Publication Language Chinese (ZH)
Filing Language Chinese (ZH)
Designated States
Title
(EN) LIQUID COMPOSITION COMPRISING ANTIBODY OF HUMAN INTERLEUKIN-4 RECEPTOR ALPHA
(FR) COMPOSITION LIQUIDE COMPRENANT UN ANTICORPS DU RÉCEPTEUR ALPHA DE L'INTERLEUKINE 4 HUMAINE
(ZH) 包含人白介素-4受体α的抗体的液体组合物
Abstract
(EN)
The present invention provides a liquid composition comprising an antibody of human interleukin-4 receptor alpha. The liquid composition comprises the antibody at a concentration of 50-200 mg/ml; and a buffer, a protectant, and a surfactant as adjuvants. The liquid composition has a pH of 5.4-6.4.
(FR)
La présente invention concerne une composition liquide comprenant un anticorps du récepteur alpha de l'interleukine 4 humaine. La composition liquide comprend l'anticorps à une concentration de 50-200 mg/ml; et un tampon, un agent protecteur et un tensioactif en tant qu'adjuvants. La composition liquide a un pH de 5,4 à 6,4.
(ZH)
本发明提供一种包含人白介素-4受体α的抗体的液体组合物,所述液体组合物包含浓度为50-200mg/ml的所述抗体;以及缓冲剂、保护剂和表面活性剂作为辅料,并且所述液体组合物具有5.4-6.4的pH。
Latest bibliographic data on file with the International Bureau